Quick Answer
TAKEDA PHARMACEUTICAL CO LTD reported Total Assets of $14.25 trillion for fiscal year 2025.
TAKEDA PHARMACEUTICAL CO LTD Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $14.25T | -5.7% |
| 2024 | $15.11T | +8.2% |
| 2023 | $13.96T | +5.9% |
| 2022 | $13.18T | +2.1% |
| 2021 | $12.91T | +0.7% |
| 2020 | $12.82T | -7.0% |
| 2019 | $13.79T | +235.9% |
| 2018 | $4.11T | — |
- TAKEDA PHARMACEUTICAL CO LTD showed a decrease of -5.7% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, TAKEDA PHARMACEUTICAL CO LTD’s total assets has grown by 247.0% (from $4.11 trillion to $14.25 trillion).
- The most recent figure is from TAKEDA PHARMACEUTICAL CO LTD’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: